Author: Dr. David Lowemann

Study: Big Shift in Users of GLP-1 Meds Like Ozempic

The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat Type 2 diabetes, a new study finds. New prescriptions for these drugs have doubled among people who have obesity but not diabetes,… Read Full Article (External Site) Dr. David LowemannDr. […]

Published on July 23, 2024

California Forges Ahead With Social Media Rules Despite Legal Barriers

California lawmakers are pursuing legislation aimed at protecting children from the dangers of social media, one of many efforts around the country to confront what U.S. Surgeon General Vivek Murthy and other public health experts say is a mental health emergency among young people. But California’s efforts, like those in other states, will likely face […]

Published on July 23, 2024

Breakthrough in skeletal muscle regeneration

In a finding that opens the door to the development of targeted therapies for various muscle disorders, newly published research identifies key mechanisms of skeletal muscle regeneration and growth of muscles following resistance exercise. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future […]

Published on July 22, 2024